Pessimistic
Last updated: 2026-03-07 08:34:04 ET
In early March 2026, Ono Pharmaceutical expanded its drug discovery collaborations with Congruence Therapeutics in neurology and immunology and partne...
International developed markets have quietly staged a comeback. Over the trailing 12 months through early March 2026, the iShares Core MSCI EAFE ETF (...
Some analysts question if petrelintide’s efficacy could impact its uptake and sales, while others tout its tolerability and combination potenti...
A patient audit of more than 1,000 lupus nephritis charts highlights growing experience with biologics and calcineurin inhibitors, alongside rising of...
March 6 () - The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U. ...
Ironwood sees Linzess rebounding in 2026 despite soft Q4 results, helped by strong prescription demand and improved net pricing.
Broker upgrades odds on AVANZAR lung cancer trial after arguing repeated delays signal strong results in treatment arm Jefferies has lifted its price ...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE